Published in Cancer Weekly, October 18th, 2005
"We determined if improved tumor detection using HAL fluorescence cystoscopy could lead to improved treatment in patients with bladder cancer. A total of 146 patients with known or suspected bladder cancer were assessed in this open, comparative, within patient, controlled phase III study. Patients received intravesical HAL for 1 hour and were assessed with standard white light cystoscopy and blue light fluorescence cystoscopy," scientists in Germany reported.
"All lesions were mapped onto a bladder chart and biopsies were taken from suspicious areas...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.